Learn more about Our impact on rare cancer research through our partnership with the Broad Institute of MIT & Harvard

THe challenge

Patients with rare cancers face poor outcomes compared to patients with common cancers. This is because progress requires data and funding, which is traditionally a challenge for rare disease research.

Our Partnership with the Broad Institute of MIT & Harvard is changing this.

““Prior to the launch of the Katie Moore Fund, there were two major barriers to progress in rare cancer research: it was impossible for patients with rare cancers at any hospital in the US to donate living samples of their cancer tissue for the creation of cell models, and in the lab, there was no proven strategy to create cell models from any rare tumor with high success rates.
With the support of the Katie Moore Foundation, we’ve overcome these two barriers.””
— Dr. Jesse Boehm, Scientific Director at The Broad Institute
 
k-3-01.png
 

Our Approach

Building a platform to accelerate the study and treatment of rare cancers in 4 steps:

1

Partnering with patients, advocates, and foundations to improve access to tumor samples for research. 

2

Using these tumor samples to map the genomic landscape of each cancer. 

3

Building cancer models (cell lines) that researchers can use as reliable models to study the cancers in the lab. 

4

Leveraging breakthrough technologies to produce a map of all the weaknesses of each tumor that might be therapeutically targetable. 

See the Latest News and Updates 

Check out our latest updates from the Katie Moore Foundation and our partners

Featured
Broad Institute's 2nd Annual Rare Cancer Symposium
Broad Institute's 2nd Annual Rare Cancer Symposium

The Broad Institute of MIT & Harvard hosted their 2nd annual Rare Cancer Symposium with this year’s focus on the Rare Cancer Dependency Map Initiative. Read on to learn about the work they are doing and how it is improving the odds of beating rare cancer!

The Story Behind Our Logo
The Story Behind Our Logo

Shortly after an extensive surgery in April of 2012, Katie got a pair of neon sneakers. She chose these glowing shoes because she thought they’d put a smile on people’s faces. Our neon logo reflects Katie’s vibrant love of life and incorporates the classic cancer ribbon into the “K”.

Collaboration = Progress